04/11/2016
https://www.congress.gov...
"Nor do we have a system that is able to track the product as it moves through the system, and a robust national system would be far preferable to a patchwork of State laws."
"I think it is a critical component of trying to create a patient-centric approach here."
"I think consumers are surprised when they learn that we do not now have a system that routinely checks to see if the drugs they are about to get are counterfeit."
"I think that would be really welcome."